Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001193125-25-309832·Ikarian Capital, LLC
Schedule 13G ownership disclosure
Tenax Therapeutics, Inc.
Common Stock, $0.0001 par value per share · CUSIP: 88032L605
Event date: 2025-11-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Ikarian Capital, LLC
Shares: 967,600 · Class: 15.5%
- Neil Shahrestani
Shares: 967,600 · Class: 15.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-309832
- Form type
- SCHEDULE 13G/A
- Filer
- Ikarian Capital, LLC
- CIK
- CIK 1778253
- Filed
- Dec 05, 2025
- Reporting period
- Nov 30, 2025
- Description
- Schedule 13G beneficial ownership